Alzheimer's Disease Protein Controls Movement In Mice, Max Delbruck Center Study

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Researchers in Berlin and Munich, Germany and Oxford, United Kingdom, have revealed that a protein well known for its role in Alzheimer's disease controls spindle development in muscle and leads to impaired movement in mice when the protein is absent or treated with inhibitors. The results, which are published in The EMBO Journal, suggest that drugs under development to target the beta-secretase-1 protein, which may be potential treatments for Alzheimer's disease, might produce unwanted side effects related to defective movement.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news